GitLab founder fights cancer with AI startups

Lavo Life Sciences provides AI-accelerated crystal structure prediction of small molecule drugs, solving a major bottleneck in pharmaceutical formulation. Vayu Robotics, acquired by Serve Robotics in 2025, uses foundation-model-based autonomy for last-mile delivery. Sijbrandij has publicly shared 25TB of osteosarcoma data at osteosarc.com, inviting the research community to study his rare cancer. The strategy emphasizes "maximum diagnostics" and parallel (rather than sequential) treatment protocols to accelerate outcomes. This represents a new model for medical breakthroughs where founders apply software-style iteration to life sciences.